Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on May 7, 2025

Treeline, Inc. Awarded by Forbes as One of America’s Best Recruiting Firms and Temporary Staffing Firms for 2025
WAKEFIELD, MA, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Treeline, Inc., a leading provider of sales recruiting and sales staffing services, is proud to announce that it has been awarded by Forbes as one of America’s Best Recruiting Firms and …

Dover, MA Digitizes Permit Process with OpenGov
TOWN OF DOVER, MA, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- After years of handling permits through a fully manual, paper-based system, the Town of Dover, MA sought a digital solution that could improve efficiency and meet rising expectations …

Creatio Partners with Bits In Glass, Welcoming Them as Premier Partner to Advance Innovation in Manufacturing
BOSTON, MA, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Creatio, a global vendor of an AI-native platform to automate workflows and CRM with no-code, has partnered with Bits In Glass (BIG), a trusted global boutique consulting firm that empowers the …

Persivia Powers the Next Era of Digital Health with Strategic $107 Million Investment and AI Innovation Patent
Fueling innovation and scale, Persivia’s $107M raise and newly patented AI engine set the stage for a smarter, faster future in healthcare. MARLBOROUGH, MA, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Persivia, the company behind one of the …

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to $12.4 …

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced today that JCO Precision Oncology published a real-world study suggesting that the results of …

MKS Instruments Reports First Quarter 2025 Financial Results
Quarterly revenue of $936 million, at the high end of guidance Quarterly GAAP net income of $52 million and net income per diluted share of $0.77, each above the midpoint of guidance Quarterly Adjusted EBITDA of $236 million, at the high end of guidance, …

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates
— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025 — Streamlining operations and focusing on delivering potential value generating program milestones, with …

ESCO Reports Second Quarter Fiscal 2025 Results
St. Louis, May 07, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the second quarter ended March 31, 2025 (Q2 2025). Operating Highlights Q2 2025 Sales increased $16.4 million (7 …

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
Catalyst Enters 2025 With Strong Momentum; Reiterates Confidence in Full-Year Outlook Delivers Record Q1 2025 Total Revenues of $141.4 Million, a 43.6% YoY Increase FIRDAPSE® and AGAMREE® Drive Sustained Organic Growth, Underscoring Execution Strength …

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …

SiTime Reports First Quarter 2025 Financial Results
SANTA CLARA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), the Precision Timing company, today announced financial results for the first quarter ended March 31, 2025. Net revenue in the first quarter of 2025 was $60.3 million …

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 7, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …

Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel
TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating its proprietary private blockchain technology, Grid Ledger System (“GLS”), today announced that it received a staff …

Veeco Announces Over $35 Million in Advanced Packaging Lithography System Orders From IDM & OSAT Customers
PLAINVIEW, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today announced its received over $35 million of orders for its AP300™ Lithography systems in recent quarters from a wide-range of IDM and OSAT customers. The orders …

Oncocyte to Release First Quarter 2025 Results on May 12, 2025
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …

Fortinet Reports First Quarter 2025 Financial Results
Highlights Total revenue of $1.54 billion, up 14% year over year Product revenue of $459 million, up 12% year over year Billings of $1.60 billion, up 14% year over year1 Unified SASE ARR2 up 26% and Security Operations ARR2 up 30%, year over year Record …

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance
ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …